Literature DB >> 32643597

Assessment of emotions and behaviour by the Developmental Behaviour Checklist in young people with neurodevelopmental CNVs.

Adam C Cunningham1, Jeremy Hall1, Stewart Einfeld2, Michael J Owen1, Marianne B M van den Bree1.   

Abstract

BACKGROUND: A number of genomic conditions caused by copy number variants (CNVs) are associated with a high risk of neurodevelopmental and psychiatric disorders (ND-CNVs). Although these patients also tend to have cognitive impairments, few studies have investigated the range of emotion and behaviour problems in young people with ND-CNVs using measures that are suitable for those with learning difficulties.
METHODS: A total of 322 young people with 13 ND-CNVs across eight loci (mean age: 9.79 years, range: 6.02-17.91, 66.5% male) took part in the study. Primary carers completed the Developmental Behaviour Checklist (DBC).
RESULTS: Of the total, 69% of individuals with an ND-CNV screened positive for clinically significant difficulties. Young people from families with higher incomes (OR = 0.71, CI = 0.55-0.91, p = .008) were less likely to screen positive. The rate of difficulties differed depending on ND-CNV genotype (χ2 = 39.99, p < 0.001), with the lowest rate in young people with 22q11.2 deletion (45.7%) and the highest in those with 1q21.1 deletion (93.8%). Specific patterns of strengths and weaknesses were found for different ND-CNV genotypes. However, ND-CNV genotype explained no more than 9-16% of the variance, depending on DBC subdomain.
CONCLUSIONS: Emotion and behaviour problems are common in young people with ND-CNVs. The ND-CNV specific patterns we find can provide a basis for more tailored support. More research is needed to better understand the variation in emotion and behaviour problems not accounted for by genotype.

Entities:  

Keywords:  Behaviour; cnv; genetics; intellectual disability; psychopathology

Mesh:

Year:  2020        PMID: 32643597      PMCID: PMC7794095          DOI: 10.1017/S0033291720002330

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  28 in total

Review 1.  Genetic studies in intellectual disability and related disorders.

Authors:  Lisenka E L M Vissers; Christian Gilissen; Joris A Veltman
Journal:  Nat Rev Genet       Date:  2015-10-27       Impact factor: 53.242

2.  The cognitive and behavioral phenotype of the 16p11.2 deletion in a clinically ascertained population.

Authors:  Ellen Hanson; Raphael Bernier; Ken Porche; Frank I Jackson; Robin P Goin-Kochel; LeeAnne Green Snyder; Anne V Snow; Arianne Stevens Wallace; Katherine L Campe; Yuan Zhang; Qixuan Chen; Debra D'Angelo; Andres Moreno-De-Luca; Patrick T Orr; K B Boomer; David W Evans; Stephen Kanne; Leandra Berry; Fiona K Miller; Jennifer Olson; Elliot Sherr; Christa L Martin; David H Ledbetter; John E Spiro; Wendy K Chung
Journal:  Biol Psychiatry       Date:  2014-06-16       Impact factor: 13.382

3.  The Developmental Behavior Checklist: the development and validation of an instrument to assess behavioral and emotional disturbance in children and adolescents with mental retardation.

Authors:  S L Einfeld; B J Tonge
Journal:  J Autism Dev Disord       Date:  1995-04

Review 4.  Recurrent copy number variations as risk factors for neurodevelopmental disorders: critical overview and analysis of clinical implications.

Authors:  Fátima Torres; Mafalda Barbosa; Patrícia Maciel
Journal:  J Med Genet       Date:  2015-10-26       Impact factor: 6.318

5.  Population prevalence of psychopathology in children and adolescents with intellectual disability: II. Epidemiological findings.

Authors:  S L Einfeld; B J Tonge
Journal:  J Intellect Disabil Res       Date:  1996-04

6.  Sleep problems and associations with psychopathology and cognition in young people with 22q11.2 deletion syndrome (22q11.2DS).

Authors:  H A Moulding; U Bartsch; J Hall; M W Jones; D E Linden; M J Owen; M B M van den Bree
Journal:  Psychol Med       Date:  2019-05-30       Impact factor: 10.592

7.  Epilepsy and seizures in young people with 22q11.2 deletion syndrome: Prevalence and links with other neurodevelopmental disorders.

Authors:  Christopher B Eaton; Rhys H Thomas; Khalid Hamandi; Gareth C Payne; Michael P Kerr; David E J Linden; Michael J Owen; Adam C Cunningham; Ullrich Bartsch; Siske S Struik; Marianne B M van den Bree
Journal:  Epilepsia       Date:  2019-04-11       Impact factor: 5.864

8.  Genotype-phenotype associations in children with copy number variants associated with high neuropsychiatric risk in the UK (IMAGINE-ID): a case-control cohort study.

Authors:  Samuel J R A Chawner; Michael J Owen; Peter Holmans; F Lucy Raymond; David Skuse; Jeremy Hall; Marianne B M van den Bree
Journal:  Lancet Psychiatry       Date:  2019-05-02       Impact factor: 77.056

9.  The clinical presentation of attention deficit-hyperactivity disorder (ADHD) in children with 22q11.2 deletion syndrome.

Authors:  Maria Niarchou; Joanna Martin; Anita Thapar; Michael J Owen; Marianne B M van den Bree
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-09-24       Impact factor: 3.568

10.  Socio-demographic patterns in hospital admissions and accident and emergency attendances among young people using linkage to NHS Hospital Episode Statistics: results from the Avon Longitudinal Study of Parents and Children.

Authors:  Leigh Johnson; Rosie Cornish; Andy Boyd; John Macleod
Journal:  BMC Health Serv Res       Date:  2019-02-26       Impact factor: 2.655

View more
  2 in total

Review 1.  Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs.

Authors:  Ida E Sønderby; Christopher R K Ching; Sophia I Thomopoulos; Dennis van der Meer; Daqiang Sun; Julio E Villalon-Reina; Ingrid Agartz; Katrin Amunts; Celso Arango; Nicola J Armstrong; Rosa Ayesa-Arriola; Geor Bakker; Anne S Bassett; Dorret I Boomsma; Robin Bülow; Nancy J Butcher; Vince D Calhoun; Svenja Caspers; Eva W C Chow; Sven Cichon; Simone Ciufolini; Michael C Craig; Benedicto Crespo-Facorro; Adam C Cunningham; Anders M Dale; Paola Dazzan; Greig I de Zubicaray; Srdjan Djurovic; Joanne L Doherty; Gary Donohoe; Bogdan Draganski; Courtney A Durdle; Stefan Ehrlich; Beverly S Emanuel; Thomas Espeseth; Simon E Fisher; Tian Ge; David C Glahn; Hans J Grabe; Raquel E Gur; Boris A Gutman; Jan Haavik; Asta K Håberg; Laura A Hansen; Ryota Hashimoto; Derrek P Hibar; Avram J Holmes; Jouke-Jan Hottenga; Hilleke E Hulshoff Pol; Maria Jalbrzikowski; Emma E M Knowles; Leila Kushan; David E J Linden; Jingyu Liu; Astri J Lundervold; Sandra Martin-Brevet; Kenia Martínez; Karen A Mather; Samuel R Mathias; Donna M McDonald-McGinn; Allan F McRae; Sarah E Medland; Torgeir Moberget; Claudia Modenato; Jennifer Monereo Sánchez; Clara A Moreau; Thomas W Mühleisen; Tomas Paus; Zdenka Pausova; Carlos Prieto; Anjanibhargavi Ragothaman; Céline S Reinbold; Tiago Reis Marques; Gabriela M Repetto; Alexandre Reymond; David R Roalf; Borja Rodriguez-Herreros; James J Rucker; Perminder S Sachdev; James E Schmitt; Peter R Schofield; Ana I Silva; Hreinn Stefansson; Dan J Stein; Christian K Tamnes; Diana Tordesillas-Gutiérrez; Magnus O Ulfarsson; Ariana Vajdi; Dennis van 't Ent; Marianne B M van den Bree; Evangelos Vassos; Javier Vázquez-Bourgon; Fidel Vila-Rodriguez; G Bragi Walters; Wei Wen; Lars T Westlye; Katharina Wittfeld; Elaine H Zackai; Kári Stefánsson; Sebastien Jacquemont; Paul M Thompson; Carrie E Bearden; Ole A Andreassen
Journal:  Hum Brain Mapp       Date:  2021-02-21       Impact factor: 5.399

2.  Using induced pluripotent stem cells to investigate human neuronal phenotypes in 1q21.1 deletion and duplication syndrome.

Authors:  Gareth Chapman; Mouhamed Alsaqati; Sharna Lunn; Tanya Singh; Stefanie C Linden; David E J Linden; Marianne B M van den Bree; Mike Ziller; Michael J Owen; Jeremy Hall; Adrian J Harwood; Yasir Ahmed Syed
Journal:  Mol Psychiatry       Date:  2021-06-10       Impact factor: 13.437

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.